BIIB
Biogen Inc. · Healthcare · Drug Manufacturers - General
TECHNeutralZACKSHold
R500#445 today
$219.88
-1.32% today · -3.39% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- BIIB −1.32% on the last session vs SPY +0.74%: −2.1 pts of stock-specific move.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Oct 28
Before the open · in 24 days
EPS estimate
$2.03
$1.44 to $2.67 · 26 analysts
Revenue estimate
$2.6B
$2.5B to $2.7B
Track record
8/8 beats
last 8 reports · moved ±3.0% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 BMO | 2Q2026 | $2.03 | $3.60 | +$1.57 (+77.4%) beat | $2.7B | +1.8% +3.3 vs SPY | +2.4% | +1.4% |
| Apr 29, 2026 BMO | 1Q2026 | $2.95 | $3.57 | +$0.62 (+20.9%) beat | $2.5B | +6.0% +6.0 vs SPY | -0.1% | +3.1% |
| Feb 6, 2026 BMO | 4Q2025 | $1.62 | $1.99 | +$0.37 (+23.2%) beat | $2.3B | +8.5% +6.6 vs SPY | +0.9% | +5.5% |
| Oct 30, 2025 BMO | 3Q2025 | $3.88 | $4.81 | +$0.93 (+23.9%) beat | $2.5B | +1.2% +2.3 vs SPY | -5.2% | +3.8% |
| Jul 31, 2025 BMO | $3.88 | $5.47 | +$1.59 (+41.0%) beat | — | +1.1% +1.4 vs SPY | +5.0% | +2.1% | |
| May 1, 2025 BMO | $2.95 | $3.02 | +$0.07 (+2.4%) beat | — | -0.1% -0.8 vs SPY | -0.6% | -3.2% | |
| Feb 12, 2025 BMO | $3.36 | $3.44 | +$0.08 (+2.4%) beat | — | -4.3% -4.0 vs SPY | -1.9% | -1.9% | |
| Oct 30, 2024 BMO | $3.79 | $4.08 | +$0.29 (+7.7%) beat | — | -1.2% -0.9 vs SPY | +0.6% | -3.6% | |
| Aug 1, 2024 BMO | $4.03 | $5.28 | +$1.25 (+31.0%) beat | — | -1.2% +0.2 vs SPY | +1.2% | -6.3% | |
| Apr 24, 2024 BMO | $3.46 | $3.67 | +$0.21 (+6.1%) beat | — | +4.6% +4.6 vs SPY | +3.0% | +11.2% | |
| Feb 13, 2024 BMO | $3.18 | $2.95 | −$0.23 (−7.2%) miss | — | -7.4% -6.0 vs SPY | -3.7% | -10.4% | |
| Nov 8, 2023 BMO | $3.98 | $4.36 | +$0.38 (+9.5%) beat | — | -5.7% -5.7 vs SPY | 0.0% | -8.3% | |
| Jul 25, 2023 BMO | $3.76 | $4.02 | +$0.26 (+6.9%) beat | — | -2.4% -2.7 vs SPY | +1.0% | -2.5% | |
| Apr 25, 2023 BMO | $3.28 | $3.40 | +$0.12 (+3.7%) beat | — | -3.6% -2.0 vs SPY | -0.7% | +6.2% | |
| Feb 15, 2023 BMO | $3.48 | $4.05 | +$0.57 (+16.4%) beat | — | -3.5% -3.8 vs SPY | -0.4% | -5.7% | |
| Oct 25, 2022 BMO | $4.13 | $4.77 | +$0.64 (+15.5%) beat | — | -0.4% -2.0 vs SPY | +1.4% | +3.2% | |
| Jul 20, 2022 BMO | $4.07 | $5.25 | +$1.18 (+29.0%) beat | — | -5.8% -6.4 vs SPY | -1.5% | -4.3% | |
| May 3, 2022 BMO | $4.36 | $3.62 | −$0.74 (−17.0%) miss | — | -0.8% -1.2 vs SPY | +0.9% | -9.5% | |
| Feb 3, 2022 BMO | $3.37 | $3.39 | +$0.02 (+0.6%) beat | — | -2.1% +0.2 vs SPY | -4.4% | +0.8% | |
| Oct 20, 2021 BMO | $4.10 | $4.77 | +$0.67 (+16.3%) beat | — | -0.6% -1.0 vs SPY | +0.7% | +1.1% | |
| Jul 22, 2021 BMO | $4.60 | $5.68 | +$1.08 (+23.5%) beat | — | — | — | — | |
| Apr 22, 2021 BMO | $4.94 | $5.34 | +$0.40 (+8.1%) beat | — | — | — | — | |
| Feb 3, 2021 BMO | $4.80 | $4.58 | −$0.22 (−4.6%) miss | — | — | — | — | |
| Oct 21, 2020 BMO | $8.05 | $8.84 | +$0.79 (+9.8%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $2.03 (26) | $1.44 – $2.67 | -58% | -48.4% | ▲1 ▼20 | $2.6B | +4% |
| Next quarter · Dec 31, 2026 | $3.27 (26) | $2.77 – $3.87 | +64% | -8.4% | ▲1 ▼1 | $2.6B | +14% |
| Current year · Dec 31, 2026 | $12.54 (33) | $12.00 – $16.39 | -18% | -5.9% | — | $10.4B | +6% |
| Next year · Dec 31, 2027 | $16.54 (33) | $13.33 – $19.29 | +32% | -0.5% | ▲2 ▼0 | $10.7B | +2% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.